Hi Daniel, am I right to assume all patients in the phase 1a will be on some sort of combination (say AC, TAC, FAC) and we then add an additional dose of Bis? If so, just trying to understand the level of complication this adds as you'd be trialling in many different drug combinations with varying allowable doses i'd have thought.
Hi Daniel, am I right to assume all patients in the phase 1a...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
0.000(0.00%) |
Mkt cap ! $273.4M | |||
| Open | High | Low | Value | Volume |
| $1.61 | $1.66 | $1.60 | $207.2K | 127.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 25510 | $1.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.64 | 12000 | 1 |
View Market Depth
| Last trade - 15.49pm 29/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |